Molecular Aspects of Allergens and Allergy

Advances in Immunology

Volumn 138, Issue , 2018, Pages 195-256

  Valenta, Rudolf ^a,b   Karaulov, Alexander ^c   Niederberger, Verena ^d   Gattinger, Pia ^a   van Hage, Marianne ^e   Flicker, Sabine ^a   Linhart, Birgit ^a   Campana, Raffaela ^a   Focke Tejkl, Margarete ^a   Curin, Mirela ^a   Eckl Dorna, Julia ^d   Lupinek, Christian ^a   Resch Marat, Yvonne ^a   Vrtala, Susanne ^a   Mittermann, Irene ^a   Garib, Victoria ^a,f   Khaitov, Musa ^b   Valent, Peter ^d   Pickl, Winfried F ^g  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INSTITUTE OF IMMUNOLOGY   (Russian Federation)

^c I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f International Network of Universities for Molecular Allergology and Immunology   (Austria)

^g MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Allergen; Allergy; Immunoglobulin E; Molecular allergology; Recombinant allergen

Indexed keywords

ALLERGEN; CD23 ANTIGEN; HLA DR1 ANTIGEN; HLA DR2 ANTIGEN; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OMALIZUMAB; IMMUNOGLOBULIN E;

ALLERGEN SPECIFIC IMMUNOTHERAPY; ALLERGENICITY; ALLERGY; ANTIGEN PRESENTING CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DENDRITIC CELL; GENOME-WIDE ASSOCIATION STUDY; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOTHERAPY; MOLECULAR DIAGNOSIS; NONHUMAN; PATHOPHYSIOLOGY; POPULATION RESEARCH; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; SENSITIZATION; TFH CELL; ANIMAL; DISEASE MODEL; HYPERSENSITIVITY; IMMUNOLOGY; PROCEDURES;

ALLERGENS; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOTHERAPY;

EID: 85046171487     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/bs.ai.2018.03.002     Document Type: Chapter

References (327)

1. Aalberse, R.C., Nieuwenhuys, E.J., Hey, M., Stapel, S.O., 'Horoscope effect' not only for seasonal but also for non-seasonal allergens. Clinical and Experimental Allergy 22:11 (1992), 1003–1006 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/1468027.
2. Akdis, M., Verhagen, J., Taylor, A., Karamloo, F., Karagiannidis, C., Crameri, R., et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. The Journal of Experimental Medicine 199:11 (2004), 1567–1575 https://doi.org/10.1084/jem.20032058.
3. Al-Kouba, J., Wilkinson, A.N., Starkey, M.R., Rudraraju, R., Werder, R.B., Liu, X., et al. (2017). Allergen-encoding bone marrow transfer inactivates allergic T cell responses, alleviating airway inflammation. Journal of Clinical Investigation Insight, 2(11). pii: 85742. https://doi.org/10.1172/jci.insight.85742.
4. Alm, J.S., Lilja, G., Pershagen, G., Scheynius, A., Early BCG vaccination and development of atopy. Lancet 350:9075 (1997), 400–403 https://doi.org/10.1016/S0140-6736(97)02207-1.
5. Altmann, F., The role of protein glycosylation in allergy. International Archives of Allergy and Immunology 142:2 (2007), 99–115 https://doi.org/10.1159/000096114.
6. Amoah, A.S., Obeng, B.B., Larbi, I.A., Versteeg, S.A., Aryeetey, Y., Akkerdaas, J.H., et al. Peanut-specific IgE antibodies in asymptomatic Ghanaian children possibly caused by carbohydrate determinant cross-reactivity. Journal of Allergy and Clinical Immunology 132:3 (2013), 639–647 https://doi.org/10.1016/j.jaci.2013.04.023.
7. Anto, J.M., Bousquet, J., Akdis, M., Auffray, C., Keil, T., Momas, I., et al. Mechanisms of the development of allergy (MeDALL): Introducing novel concepts in allergy phenotypes. Journal of Allergy and Clinical Immunology 139:2 (2017), 388–399 https://doi.org/10.1016/j.jaci.2016.12.940.
8. Apostolovic, D., Krstic, M., Mihailovic, J., Starkhammar, M., Cirkovic Velickovic, T., et al. Peptidomics of an in vitro digested α-Gal carrying protein revealed IgE-reactive peptides. Scientific Reports, 7(1), 2017, 5201 https://doi.org/10.1038/s41598-017-05355-4.
9. Asarnoj, A., Hamsten, C., Lupinek, C., Melén, E., Andersson, N., Anto, J.M., et al. Prediction of peanut allergy in adolescence by early childhood storage protein-specific IgE signatures: The BAMSE population-based birth cohort. Journal of Allergy and Clinical Immunology 140:2 (2017), 587–590 https://doi.org/10.1016/j.jaci.2016.12.973.
10. Asarnoj, A., Hamsten, C., Wadén, K., Lupinek, C., Andersson, N., Kull, I., et al. Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: A BAMSE/MeDALL study. Journal of Allergy and Clinical Immunology 137:3 (2016), 813–821 https://doi.org/10.1016/j.jaci.2015.09.052.
11. Baar, A., Pahr, S., Constantin, C., Giavi, S., Papadopoulos, N.G., Pelkonen, A.S., et al. The high molecular weight glutenin subunit Bx7 allergen from wheat contains repetitive IgE epitopes. Allergy 69:10 (2014), 1316–1323 https://doi.org/10.1111/all.12464.
12. Bacher, P., Heinrich, F., Stervbo, U., Nienen, M., Vahldieck, M., Iwert, C., et al. Regulatory T cell specificity directs tolerance versus allergy against aeroantigens in humans. Cell 167:4 (2016), 1067–1078 https://doi.org/10.1016/j.cell.2016.09.050.
13. Banerjee, S., Weber, M., Blatt, K., Swoboda, I., Focke-Tejkl, M., Valent, P., et al. Conversion of Der p 23, a new major house dust mite allergen, into a hypoallergenic vaccine. Journal of Immunology 192:10 (2014), 4867–4875 https://doi.org/10.4049/jimmunol.1400064.
14. Baranyi, U., Farkas, A.M., Hock, K., Mahr, B., Linhart, B., Gattringer, M., et al. Cell therapy for prophylactic tolerance in immunoglobulin E-mediated allergy. eBioMedicine 7 (2016), 230–239 https://doi.org/ https://doi.org/10.1016/j.ebiom.2016.03.028.
15. Baranyi, U., Gattringer, M., Farkas, A.M., Hock, K., Pilat, N., Iacomini, J., et al. The site of allergen expression in hematopoietic cells determines the degree and quality of tolerance induced through molecular chimerism. European Journal of Immunology 43:9 (2013), 2451–2460 https://doi.org/10.1002/eji.201243277.
16. Baranyi, U., Gattringer, M., Valenta, R., Wekerle, T., Cell-based therapy in allergy. Current Topics in Microbiology and Immunology 352 (2011), 161–179 https://doi.org/10.1007/82_2011_127.
17. Baranyi, U., Linhart, B., Pilat, N., Gattringer, M., Bagley, J., Muehlbacher, F., et al. Tolerization of a type I allergic immune response through transplantation of genetically modified hematopoietic stem cells. Journal of Immunology 180:12 (2008), 8168–8175 Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993923.
18. Baranyi, U., Pilat, N., Gattringer, M., Linhart, B., Klaus, C., Schwaiger, E., et al. Persistent molecular microchimerism induces long-term tolerance towards a clinically relevant respiratory allergen. Clinical and Experimental Allergy 42:8 (2012), 1282–1292 https://doi.org/10.1111/j.1365-2222.2012.04049.x.
19. Benedé, S., Blázquez, A.B., Chiang, D., Tordesillas, L., Berin, M.C., The rise of food allergy: Environmental factors and emerging treatments. eBioMedicine 7 (2016), 27–34 https://doi.org/10.1016/j.ebiom.2016.04.012.
20. Bennich, H.H., Ishizaka, K., Johansson, S.G., Rowe, D.S., Stanworth, D.R., Terry, W.D., Immunoglobulin E: A new class of human immunoglobulin. Immunology 15:3 (1968), 323–324 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/4176102.
21. Bernasconi, N.L., Traggiai, E., Lanzavecchia, A., Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298:5601 (2002), 2199–2202 https://doi.org/10.1126/science.1076071.
22. Bernstein, D.I., Schwartz, G., Bernstein, J.A., Allergic rhinitis: Mechanisms and treatment. Immunology and Allergy Clinics of North America 36:2 (2016), 261–278 https://doi.org/10.1016/j.iac.2015.12.004.
23. Bhalla, P.L., Swoboda, I., Singh, M.B., Antisense-mediated silencing of a gene encoding a major ryegrass pollen allergen. Proceedings of the National Academy of Sciences of the United States of America 96:20 (1999), 11676–11680 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC18093.
24. Billingham, R.E., Brent, L., Medawar, P.B., Actively acquired tolerance of foreign cells. Nature 172:4379 (1953), 603–606 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/13099277.
25. Blank, U., Charles, N., Benhamou, M., The high-affinity immunoglobulin E receptor as pharmacological target. European Journal of Pharmacology 778 (2016), 24–32 https://doi.org/10.1016/j.ejphar.2015.05.070.
26. Breiteneder, H., Pettenburger, K., Bito, A., Valenta, R., Kraft, D., Rumpold, H., et al. The gene coding for the major birch pollen allergen Betv1, is highly homologous to a pea disease resistance response gene. The EMBO Journal 8:7 (1989), 1935–1938 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC401053.
27. Brent, L., Transplantation tolerance-a historical introduction. Immunology 147:3 (2016), 267–268 https://doi.org/10.1111/imm.12567.
28. Brightbill, H.D., Jeet, S., Lin, Z., Yan, D., Zhou, M., Tan, M., et al. Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized mice. Journal of Clinical Investigation 120:6 (2010), 2218–2229 https://doi.org/10.1172/JCI40141.
29. Briner, T.J., Kuo, M.C., Keating, K.M., Rogers, B.L., Greenstein, J.L., Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I. Proceedings of the National Academy of Sciences of the United States of America 90:16 (1993), 7608–7612 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC47191.
30. Brunetto, B., Tinghino, R., Braschi, M.C., Antonicelli, L., Pini, C., Iacovacci, P., Characterization and comparison of commercially available mite extracts for in vivo diagnosis. Allergy 65:2 (2010), 184–190 https://doi.org/10.1111/j.1398-9995.2009.02150.x.
31. Cabauatan, C.R., Lupinek, C., Scheiblhofer, S., Weiss, R., Focke-Tejkl, M., Bhalla, P.L., et al. Allergen microarray detects high prevalence of asymptomatic IgE sensitizations to tropical pollen-derived carbohydrates. Journal of Allergy and Clinical Immunology 133:3 (2014), 910–914 https://doi.org/10.1016/j.jaci.2013.10.004.
32. Campana, R., Dzoro, S., Mittermann, I., Fedenko, E., Elisyutina, O., Khaitov, M., et al. Molecular aspects of allergens in atopic dermatitis. Current Opinion in Allergy and Clinical Immunology 17:4 (2017), 269–277 https://doi.org/10.1097/ACI.0000000000000378.
33. Campana, R., Huang, H.J., Freidl, R., Linhart, B., Vrtala, S., Wekerle, T., et al. Recombinant allergen and peptide-based approaches for allergy prevention by oral tolerance. Seminars in Immunology 30 (2017), 67–80 https://doi.org/ https://doi.org/10.1016/j.smim.2017.08.017.
34. Campana, R., Moritz, K., Marth, K., Neubauer, A., Huber, H., Henning, R., et al. Frequent occurrence of T cell-mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments. Journal of Allergy and Clinical Immunology 137:2 (2016), 601–609 https://doi.org/10.1016/j.jaci.2015.08.042.
35. Campana, R., Moritz, K., Neubauer, A., Huber, H., Henning, R., Brodie, T.M., et al. Epicutaneous allergen application preferentially boosts specific T cell responses in sensitized patients. Scientific Reports, 7(1), 2017, 11657 https://doi.org/10.1038/s41598-017-10278-1.
36. Campana, R., Mothes, N., Rauter, I., Vrtala, S., Reininger, R., Focke-Tejkl, M., et al. Non-IgE-mediated chronic allergic skin inflammation revealed with rBet v 1 fragments. Journal of Allergy and Clinical Immunology 121:2 (2008), 528–530 https://doi.org/10.1016/j.jaci.2007.09.014.
37. Campana, R., Vrtala, S., Maderegger, B., Dall'Antonia, Y., Zafred, D., Blatt, K., Altered IgE epitope presentation: A model for hypoallergenic activity revealed for Bet v 1 trimer. Molecular Immunology 48:4 (2011), 431–441 https://doi.org/10.1016/j.molimm.2010.09.016.
38. 2 LEN consensus document on molecular-based allergy diagnostics. World Allergy Organization Journal, 6(1), 2013, 17 https://doi.org/10.1186/1939-4551-6-17.
39. Carbone, F.R., Bevan, M.J., Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. Journal of Experimental Medicine 171:2 (1990), 377–387 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2187713.
40. Casset, A., Mari, A., Purohit, A., Resch, Y., Weghofer, M., Ferrara, R., et al. Varying allergen composition and content affects the in vivo allergenic activity of commercial Dermatophagoides pteronyssinus extracts. International Archives of Allergy and Immunology 159:3 (2012), 253–262 https://doi.org/10.1159/000337654.
41. Charlesworth, E.N., Hood, A.F., Soter, N.A., Kagey-Sobotka, A., Norman, P.S., Lichtenstein, L.M., Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. The Journal of Clinical Investigation 83:5 (1989), 1519–1526 https://doi.org/10.1172/JCI114047.
42. Chase, M.W., Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proceedings of the Society for Experimental Biology and Medicine 61 (1946), 257–259 Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK327.
43. Chen, K.W., Focke-Tejkl, M., Blatt, K., Kneidinger, M., Gieras, A., Dall'Antonia, F., et al. Carrier-bound nonallergenic Der p 2 peptides induce IgG antibodies blocking allergen-induced basophil activation in allergic patients. Allergy 67:5 (2012), 609–621 https://doi.org/10.1111/j.1398-9995.2012.02794.x.
44. Christensen, L.H., Holm, J., Lund, G., Riise, E., Lund, K., Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge. Journal of Allergy and Clinical Immunology 122:2 (2008), 298–304 https://doi.org/10.1016/j.jaci.2008.05.026.
45. Chua, K.Y., Stewart, G.A., Thomas, W.R., Simpson, R.J., Dilworth, R.J., Plozza, T.M., et al. Sequence analysis of cDNA coding for a major house dust mite allergen, Der p 1. Homology with cysteine proteases. The Journal of Experimental Medicine 167:1 (1988), 175–178 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188807.
46. Commins, S.P., James, H.R., Kelly, L.A., Pochan, S.L., Workman, L.J., Perzanowski, M.S., et al. The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-α-1,3-galactose. Journal of Allergy and Clinical Immunology (Trans.) 5, 127, 2011, 1286–1293 e6 https://doi.org/10.1016/j.jaci.2011.02.019.
47. Constant, S.L., Lee, K.S., Bottomly, K., Site of antigen delivery can influence T cell priming: Pulmonary environment promotes preferential Th2-type differentiation. European Journal of Immunology 30:3 (2000), 840–847 https://doi.org/10.1002/1521-4141(200003)30:3%3C840::AID-IMMU840%3E3.0.CO;2-L.
48. Constant, S., Schweitzer, N., West, J., Ranney, P., Bottomly, K., B lymphocytes can be competent antigen-presenting cells for priming CD4 + T cells to protein antigens in vivo. Journal of Immunology 155:8 (1995), 3734–3741 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/7561077.
49. Cooke, R.A., Barnard, J.H., Hebald, S., Stull, A., Serological evidence of immunity with coexisting sensitization in a type of human allergy (hay fever). The Journal of Experimental Medicine 62:6 (1935), 733–750 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/19870445.
50. Cookson, W.O., Hopkin, J.M., Dominant inheritance of atopic immunoglobulin-E responsiveness. Lancet 1:8577 (1988), 86–88 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/2891984.
51. Coombs, R.R.A., Gell, P.G.H., Classification of allergic reactions responsible for clinical hypersensitivity and disease. Gell, P.G.H., Coombs, R.R.A., Lachmann, P.J., (eds.) Clinical aspects of immunology, 3rd ed., 1975, Blackwell Scientific Publications, Oxford, 761–781.
52. Cornelius, C., Schöneweis, K., Georgi, F., Weber, M., Niederberger, V., Zieglmayer, P., et al. Immunotherapy with the PreS-based grass pollen allergy vaccine BM32 induces antibody responses protecting against hepatitis B infection. eBioMedicine 11 (2016), 58–67 https://doi.org/10.1016/j.ebiom.2016.07.023.
53. Cox, L., Allergy immunotherapy in reducing healthcare cost. Current Opinion in Otolaryngology & Head and Neck Surgery 23:3 (2015), 247–254 https://doi.org/10.1097/MOO.0000000000000150.
54. Cox, L., The role of allergen immunotherapy in the management of allergic rhinitis. American Journal of Rhinology & Allergy 30:1 (2016), 48–53 https://doi.org/10.2500/ajra.2016.30.4253.
55. Creticos, P.S., Schroeder, J.T., Hamilton, R.G., Balcer-Whaley, S.L., Khattignavong, A.P., Lindblad, R., et al. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. The New England Journal of Medicine 355:14 (2006), 1445–1455 https://doi.org/10.1056/NEJMoa052916.
56. Crotty, S., A brief history of T cell help to B cells. Nature Reviews. Immunology 15:3 (2015), 185–189 https://doi.org/10.1038/nri3803.
57. Curin, M., Garmatiuk, T., Resch-Marat, Y., Chen, K.W., Hofer, G., Fauland, K., et al. Similar localization of conformational IgE epitopes on the house dust mite allergens Der p 5 and Der p 21 despite limited IgE cross-reactivity. Allergy, 2018 https://doi.org/10.1111/all.13398.
58. Curin, M., Swoboda, I., Wollmann, E., Lupinek, C., Spitzauer, S., van Hage, M., et al. Microarrayed dog, cat, and horse allergens show weak correlation between allergen-specific IgE and IgG responses. Journal of Allergy and Clinical Immunology 133:3 (2014), 918–921 https://doi.org/10.1016/j.jaci.2013.10.058.
59. Curin, M., Weber, M., Hofer, G., Apostolovic, D., Keller, W., Reininger, R., et al. Clustering of conformational IgE epitopes on the major dog allergen Can f 1. Scientific Reports, 7(1), 2017, 12135 https://doi.org/10.1038/s41598-017-11672-5.
60. Custovic, A., Sonntag, H.J., Buchan, I.E., Belgrave, D., Simpson, A., Prosperi, M.C.F., et al. Evolution pathways of IgE responses to grass and mite allergens throughout childhood. Journal of Allergy and Clinical Immunology 136:6 (2015), 1645–1652 https://doi.org/10.1016/j.jaci.2015.03.041.
61. D'Amato, M., Picardi, A., Menna, T., Di Somma, C., Ariano, R., di Pietro, A., et al. HLA-DRB1* and allergy to parietaria: Linkage and association analyses. Human Immunology 60:12 (1999), 1250–8125 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/10626739.
62. David, M.F., Prevention of homocytotropic antibody formation and anaphylactic sensitization by prefeeding antigen. Journal of Allergy and Clinical Immunology 60:3 (1977), 180–187 Retrieved from europepmc.org/abstract/med/893876.
63. Diaz-Sanchez, D., Tsien, A., Fleming, J., Saxon, A., Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern. Journal of Immunology 158:5 (1997), 2406–2413 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/9036991.
64. Drucker, A.M., Atopic dermatitis: Burden of illness, quality of life, and associated complications. Allergy and Asthma Proceedings 38:1 (2017), 3–8 https://doi.org/10.2500/aap.2017.38.4005.
65. Dullaers, M., Schuijs, M.J., Willart, M., Fierens, K., Van Moorleghem, J., Hammad, H., et al. House dust mite-driven asthma and allergen-specific T cells depend on B cells when the amount of inhaled allergen is limiting. Journal of Allergy and Clinical Immunology 140:1 (2017), 76–88 https://doi.org/10.1016/j.jaci.2016.09.020.
66. Dunbar, W.P., Zur Ursache und spezifischen Heilung des Heufiebers. Deutsche Medizinische Wochenschrift 9 (1903), 24–28.
67. Durham, S.R., Gould, H.J., Thienes, C.P., Jacobson, M.R., Masuyama, K., Rak, S., et al. Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid. European Journal of Immunology 27:11 (1997), 2899–2906 https://doi.org/10.1002/eji.1830271123.
68. Durham, S.R., Schwabe, C., Robson, R., Ahlström Emanuelsson, C., Shamji, M., Singh, D., et al. A randomized clinical trial of passive immunotherapy with single-dose anti-Fel d 1 monoclonal antibodies REGN 1908–1909 in cat induced rhinoconjunctivitis: Exploratory efficacy endpoints, safety. Allergy 72:Suppl. S103 (2017), 64–65.
69. Durham, S.R., Walker, S.M., Varga, E.M., Jacobson, M.R., O'Brien, F., Noble, W., et al. Long-term clinical efficacy of grass-pollen immunotherapy. The New England Journal of Medicine 341:7 (1999), 468–475 https://doi.org/10.1056/NEJM199908123410702.
70. Durham, S.R., Yang, W.H., Pedersen, M.R., Johansen, N., Rak, S., Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitis. Journal of Allergy and Clinical Immunology 117:4 (2006), 802–809 https://doi.org/10.1016/j.jaci.2005.12.1358.
71. Eckl-Dorna, J., Campana, R., Valenta, R., Niederberger, V., Poor association of allergen-specific antibody, T- and B-cell responses revealed with recombinant allergens and a CFSE dilution-based assay. Allergy 70:10 (2015), 1222–1229 https://doi.org/10.1111/all.12661.
72. Eckl-Dorna, J., Ellinger, A., Blatt, K., Ghanim, V., Steiner, I., Pavelka, M., et al. Basophils are not the key antigen-presenting cells in allergic patients. Allergy 67:5 (2012), 601–608 https://doi.org/10.1111/j.1398-9995.2012.02792.x.
73. Eckl-Dorna, J., Fröschl, R., Lupinek, C., Kiss, R., Gattinger, P., Marth, K., et al. Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels—A pilot study. Allergy, 2017 https://doi.org/10.1111/all.13343.
74. Eckl-Dorna, J., Klein, B., Reichenauer, T.G., Niederberger, V., Valenta, R., Exposure of rye (Secale cereale) cultivars to elevated ozone levels increases the allergen content in pollen. Journal of Allergy and Clinical Immunology 126:6 (2010), 1315–1317 https://doi.org/10.1016/j.jaci.2010.06.012.
75. Eckl-Dorna, J., Pree, I., Reisinger, J., Marth, K., Chen, K.W., Vrtala, S., et al. The majority of allergen-specific IgE in the blood of allergic patients does not originate from blood-derived B cells or plasma cells. Clinical and Experimental Allergy 42:9 (2012), 1347–1355 https://doi.org/10.1111/j.1365-2222.2012.04030.x.
76. Edlmayr, J., Niespodziana, K., Linhart, B., Focke-Tejkl, M., Westritschnig, K., Scheiblhofer, S., et al. A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1. Journal of Immunology 182:10 (2009), 6298–6306 https://doi.org/10.4049/jimmunol.0713622.
77. Ege, M.J., Mayer, M., Normand, A.C., Genuneit, J., Cookson, W.O., Braun-Fahrländer, C., et al. Exposure to environmental microorganisms and childhood asthma. The New England Journal of Medicine 364:8 (2011), 701–709 https://doi.org/10.1056/NEJMoa1007302.
78. Egger, C., Horak, F., Vrtala, S., Valenta, R., Niederberger, V., Nasal application of rBet v 1 or non-IgE-reactive T-cell epitope-containing rBet v 1 fragments has different effects on systemic allergen-specific antibody responses. Journal of Allergy and Clinical Immunology 126:6 (2010), 1312–1315 https://doi.org/10.1016/j.jaci.2010.06.008.
79. Egger, C., Lupinek, C., Ristl, R., Lemell, P., Horak, F., Zieglmayer, P., et al. Effects of nasal corticosteroids on boosts of systemic allergen-specific IgE production induced by nasal allergen exposure. PLoS One, 10(2), 2005, e0114991 https://doi.org/10.1371/journal.pone.0114991.
80. Eisenbrey, A.B., Agarwal, M.K., Offord, K.P., Adolphson, C.R., Yunginger, J.W., Gleich, G.J., Seasonal variation of in vitro lymphocyte proliferative response to ragweed antigen E. Journal of Allergy and Clinical Immunology 75:1 Pt 1 (1985), 84–90 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/3968332.
81. Epstein, T.G., Liss, G.M., Murphy-Berendts, K., Bernstein, D.I., Risk factors for fatal and nonfatal reactions to subcutaneous immunotherapy: National surveillance study on allergen immunotherapy (2008–2013). Annals of Allergy, Asthma & Immunology 116:4 (2016), 354–359 e2 https://doi.org/10.1016/j.anai.2016.02.001.
82. Fallon, P.G., Sasaki, T., Sandilands, A., Campbell, L.E., Saunders, S.P., Mangan, N.E., et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nature Genetics 41:5 (2009), 602–608 https://doi.org/10.1038/ng.358.
83. Fang, K.S., Vitale, M., Fehlner, P., King, T.P., cDNA cloning and primary structure of a white-face hornet venom allergen, antigen 5. Proceedings of the National Academy of Sciences of the United States of America. 85:3 (1988), 895–899 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC279663.
84. Farber, D.L., Netea, M.G., Radbruch, A., Rajewsky, K., Zinkernagel, R.M., Immunological memory: Lessons from the past and a look to the future. Nature Reviews. Immunology 16:2 (2016), 124–128 https://doi.org/10.1038/nri.2016.13.
85. Fedenko, E., Elisyutina, O., Shtyrbul, O., Pampura, A., Valenta, R., Lupinek, C., et al. Microarray-based IgE serology improves management of severe atopic dermatitis in two children. Pediatric Allergy and Immunology 27:6 (2016), 645–649 https://doi.org/10.1111/pai.12572.
86. Ferreira, F., Hawranek, T., Gruber, P., Wopfner, N., Mari, A., Allergic cross-reactivity: From gene to the clinic. Allergy 59:3 (2014), 243–267 https://doi.org/10.1046/j.1398-9995.2003.00407.x.
87. Ferreira, F., Hirtenlehner, K., Jilek, A., Godnik-Cvar, J., Breiteneder, H., Grimm, R., et al. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: Potential use of hypoallergenic isoforms for immunotherapy. The Journal of Experimental Medicine 183:2 (1996), 599–609 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192443.
88. Finkelman, F.D., Rothenberg, M.E., Brandt, E.B., Morris, S.C., Strait, R.T., Molecular mechanisms of anaphylaxis: Lessons from studies with murine models. Journal of Allergy and Clinical Immunology 115:3 (2005), 449–457 https://doi.org/10.1016/j.jaci.2004.12.1125.
89. Fischer, G.F., Pickl, W.F., Faé, I., Ebner, C., Ferreira, F., Breiteneder, H., et al. Association between IgE response against Bet v I, the major allergen of birch pollen, and HLA-DRB alleles. Human Immunology 33:4 (1992), 259–265 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/1353487.
90. Flicker, S., Linhart, B., Wild, C., Wiedermann, U., Valenta, R., Passive immunization with allergen-specific IgG antibodies for treatment and prevention of allergy. Immunobiology 218:6 (2013), 884–891 https://doi.org/10.1016/j.imbio.2012.10.008.
91. Flicker, S., Marth, K., Kofler, H., Valenta, R., Placental transfer of allergen-specific IgG but not IgE from a specific immunotherapy-treated mother. Journal of Allergy and Clinical Immunology 124:6 (2009), 1358–1360 https://doi.org/10.1016/j.jaci.2009.09.024.
92. Flicker, S., Steinberger, P., Ball, T., Krauth, M.T., Verdino, P., Valent, P., et al. Spatial clustering of the IgE epitopes on the major timothy grass pollen allergen Phl p 1: Importance for allergenic activity. Journal of Allergy and Clinical Immunology 117:6 (2006), 1336–1343 https://doi.org/10.1016/j.jaci.2006.02.012.
93. Focke, M., Marth, K., Flicker, S., Valenta, R., Heterogeneity of commercial timothy grass pollen extracts. Clinical and Experimental Allergy 38:8 (2008), 1400–1408 https://doi.org/10.1111/j.1365-2222.2008.03031.x.
94. Focke, M., Swoboda, I., Marth, K., Valenta, R., Developments in allergen-specific immunotherapy: From allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity. Clinical and Experimental Allergy 40:3 (2010), 385–397 https://doi.org/10.1111/j.1365-2222.2009.03443.x.
95. Focke-Tejkl, M., Campana, R., Reininger, R., Lupinek, C., Blatt, K., Valent, P., et al. Dissection of the IgE and T-cell recognition of the major group 5 grass pollen allergen Phl p 5. Journal of Allergy and Clinical Immunology 133:3 (2014), 836–845 https://doi.org/10.1016/j.jaci.2013.08.038.
96. Focke-Tejkl, M., Weber, M., Niespodziana, K., Neubauer, A., Huber, H., Henning, R., et al. Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy. Journal of Allergy and Clinical Immunology 135:5 (2015), 1207–1217, 10.1016/j.jaci.2014.09.012.
97. Frankland, A.W., & Augustin, R. (1954). Prophylaxis of summer hay-fever and asthma: A controlled trial comparing crude grass-pollen extracts with the isolated main protein component. Lancet 266, 1055–1057. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/13164324.
98. Gadermaier, E., Levin, M., Flicker, S., Ohlin, M., The human IgE repertoire. International Archives of Allergy and Immunology 163:2 (2014), 77–91 https://doi.org/10.1159/000355947.
99. Gangl, K., Reininger, R., Bernhard, D., Campana, R., Pree, I., Reisinger, J., et al. Cigarette smoke facilitates allergen penetration across respiratory epithelium. Allergy 64:3 (2009), 398–405 https://doi.org/10.1111/j.1398-9995.2008.01861.x.
100. Gangl, K., Waltl, E.E., Vetr, H., Cabauatan, C.R., Niespodziana, K., Valenta, R., et al. Infection with rhinovirus facilitates allergen penetration across a respiratory epithelial cell layer. International Archives of Allergy and Immunology 166:4 (2015), 291–296 https://doi.org/10.1159/000430441.
101. Garib, V., Wollmann, E., Djambekova, G., Lemell, P., Kmenta, M., Berger, U., et al. Possible effect of landscape design on IgE recognition profiles of two generations revealed with micro-arrayed allergens. Allergy 72:10 (2017), 1579–1582 https://doi.org/10.1111/all.13169.
102. Gauvreau, G.M., Boulet, L.P., Cockcroft, D.W., FitzGerald, J.M., Mayers, I., Carlsten, C., et al. OX40L blockade and allergen-induced airway responses in subjects with mild asthma. Clinical and Experimental Allergy 44:1 (2014), 29–37 https://doi.org/10.1111/cea.12235.
103. Gauvreau, G.M., Harris, J.M., Boulet, L.P., Scheerens, H., Fitzgerald, J.M., Putnam, W.S., et al. Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production. Science Translational Medicine, 6(243), 2014, 243ra85 https://doi.org/10.1126/scitranslmed.3008961.
104. Gieras, A., Cejka, P., Blatt, K., Focke-Tejkl, M., Linhart, B., Flicker, S., et al. Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1. Journal of Immunology 186:9 (2011), 5333–5344 https://doi.org/10.4049/jimmunol.1000804.
105. Gieras, A., Focke-Tejkl, M., Ball, T., Verdino, P., Hartl, A., Thalhamer, J., et al. Molecular determinants of allergen-induced effector cell degranulation. Journal of Allergy and Clinical Immunology 119:2 (2007), 384–390 https://doi.org/10.1016/j.jaci.2006.09.034.
106. Gieras, A., Linhart, B., Roux, K.H., Dutta, M., Khodoun, M., Zafred, D., et al. IgE epitope proximity determines immune complex shape and effector cell activation capacity. Journal of Allergy and Clinical Immunology 137:5 (2016), 1557–1565 https://doi.org/10.1016/j.jaci.2015.08.055.
107. Glovsky, M.M., Ghekiere, L., Rejzek, E., Effect of maternal immunotherapy on immediate skin test reactivity, specific rye I IgG and IgE antibody, and total IgE of the children. Annals of Allergy, Asthma & Immunology 67:1 (1991), 21–24 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/1859036.
108. Göbl, C., Focke-Tejkl, M., Najafi, N., Schrank, E., Madl, T., Kosol, S., et al. Flexible IgE epitope-containing domains of Phl p 5 cause high allergenic activity. Journal of Allergy and Clinical Immunology 140:4 (2017), 1187–1191 https://doi.org/10.1016/j.jaci.2017.05.005.
109. Gour, N., Lajoie, S., Smole, U., White, M., Hu, D., Goddard, P. et al. (2018). Dysregulated invertebrate tropomyosin-dectin-1 interaction confers susceptibility to allergic diseases. Science Immunology, 3(20). pii: pii: eaam9841. https://doi.org/10.1126/sciimmunol.aam9841.
110. Grabenhenrich, L.B., Dölle, S., Moneret-Vautrin, A., Köhli, A., Lange, L., Spindler, T., et al. Anaphylaxis in children and adolescents: The European Anaphylaxis Registry. Journal of Allergy and Clinical Immunology 137:4 (2016), 1128–1137 https://doi.org/10.1016/j.jaci.2015.11.015.
111. Graf, N., Johansen, P., Schindler, C., Wuthrich, B., Ackermann-Liebrich, U., Gassner, M., et al. Analysis of the relationship between pollinosis and date of birth in Switzerland. International Archives of Allergy and Immunolology 143:4 (2007), 269–275 https://doi.org/10.1159/000100572.
112. Hamelmann, E., Tadeda, K., Oshiba, A., Gelfand, E.W., Role of IgE in the development of allergic airway inflammation and airway hyperresponsiveness—A murine model. Allergy 54:4 (1999), 297–305 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/10371087.
113. Hammad, H., Plantinga, M., Deswarte, K., Pouliot, P., Willart, M.A., Kool, M., et al. Inflammatory dendritic cells—Not basophils—Are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. The Journal of Experimental Medicine 207:10 (2010), 2097–2111 https://doi.org/10.1084/jem.20101563.
114. Hamsten, C., Tran, T.A.T., Starkhammar, M., Brauner, A., Commins, S.P., Platts-Mills, T.A.E., et al. Red meat allergy in Sweden: Association with tick sensitization and B-negative blood groups. Journal of Allergy and Clinical Immunology 132:6 (2013), 1431–1434 https://doi.org/10.1016/j.jaci.2013.07.050.
115. Hansel, T.T., Johnston, S.L., Openshaw, P.J., Microbes and mucosal immune responses in asthma. Lancet 381:9869 (2013), 861–873 https://doi.org/10.1016/S0140-6736(12)62202-8.
116. Hansel, T.T., Tunstall, T., Trujillo-Torralbo, M.B., Shamji, B., Del-Rosario, A., Dhariwal, J., et al. A comprehensive evaluation of nasal and bronchial cytokines and chemokines following experimental rhinovirus infection in allergic asthma: Increased interferons (IFN-γ and IFN-λ) and type 2 inflammation (IL-5 and IL-13). eBioMedicine 19 (2017), 128–138 https://doi.org/10.1016/j.ebiom.2017.03.033.
117. Hansen, J.S., Nygaard, U.C., Lyle, R., Lovik, M., Early life interventions to prevent allergy in the offspring: the role of maternal immunization and postnatal mucosal allergen exposure. International Archives of Allergy and Immunology 158:3 (2012), 261–275 https://doi.org/10.1159/000332963.
118. Harwanegg, C., Laffer, S., Hiller, R., Mueller, M.W., Kraft, D., Spitzauer, S., et al. Microarrayed recombinant allergens for diagnosis of allergy. Clinical and Experimental Allergy 33:1 (2003), 7–13.
119. Harb, H., Renz, H., Update on epigenetics in allergic disease. Journal of Allergy and Clinical Immunology 135:1 (2015), 15–24 https://doi.org/10.1016/j.jaci.2014.11.009.
120. Haselden, B.M., Kay, A.B., Larché, M., Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. The Journal of Experimental Medicine 189:12 (1999), 1885–1894 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192970.
121. Hatzler, L., Panetta, V., Lau, S., Wagner, P., Bergmann, R.L., Illi, S., et al. Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. Journal of Allergy and Clinical Immunology 130:4 (2012), 894–901 https://doi.org/10.1016/j.jaci.2012.05.053.
122. He, J.S., Subramaniam, S., Narang, V., Srinivasan, K., Saunders, S.P., Carbajo, D., et al. IgG1 memory B cells keep the memory of IgE responses. Nature Communications, 8(1), 2017, 641 https://doi.org/10.1038/s41467-017-00723-0.
123. Hebeis, B.J., Klenovsek, K., Rohwer, P., Ritter, U., Schneider, A., Mach, M., et al. Activation of virus-specific memory B cells in the absence of T cell help. The Journal of Experimental Medicine 199:4 (2004), 593–602 https://doi.org/10.1084/jem.20030091.
124. Helm, S.L., Burton, G.F., Szakal, A.K., Tew, J.G., Follicular dendritic cells and the maintenance of IgE responses. European Journal of Immunology 25:8 (1995), 2362–2369 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/7664798.
125. Henderson, L.L., Larson, J.B., Gleich, G.J., Maximal rise in IgE antibody following ragweed pollination season. Journal of Allergy and Clinical Immunology 55:1 (1975), 10–15 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/2563270.
126. Hennino, A., Vocanson, M., Toussaint, Y., Rodet, K., Benetière, J., Schmitt, A.M., et al. Skin-infiltrating CD8 + T cells initiate atopic dermatitis lesions. Journal of Immunology 178:9 (2007), 5571–5577 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/17442939.
127. Herz, U., Lumpp, U., Daser, A., Gelfand, E.W., Renz, H., Murine animal models to study the central role of T cells in immediate-type hypersensitivity responses. Advances in Experimental Medicine and Biology 409 (1996), 25–32 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/9095220.
128. Hewitt, C.R., Brown, A.P., Hart, B.J., Pritchard, D.I., A major house dust mite allergen disrupts the immunoglobulin E network by selectively cleaving CD23: Innate protection by antiproteases. The Journal of Experimental Medicine 182:5 (1995), 1537–1544 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192194.
129. Hijnen, D., Knol, E.F., Gent, Y.Y., Giovannone, B., Beijn, S.J., Kupper, T.S., et al. CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-γ, IL-13, IL-17, and IL-22. The Journal of Investigative Dermatology 133:4 (2013), 973–979 https://doi.org/10.1038/jid.2012.456.
130. Hiller, R., Laffer, S., Harwanegg, C., Huber, M., Schmidt, W.M., Twardosz, A., et al. Microarrayed allergen molecules: Diagnostic gatekeepers for allergy treatment. The FASEB Journal 16:3 (2002), 414–416, 10.1096/fj.01-0711fje.
131. Hinds, D.A., McMahon, G., Kiefer, A.K., Do, C.B., Eriksson, N., Evans, D.M., et al. A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci. Nature Genetics 45:8 (2013), 907–911 https://doi.org/ https://doi.org/10.1038/ng.2686.
132. Hjort, C., Schiøtz, P.O., Ohlin, M., Würtzen, P.A., Christensen, L.H., Hoffmann, H.J., The number and affinity of productive IgE pairs determine allergen activation of mast cells. Journal of Allergy and Clinical Immunology 140:4 (2017), 1167–1170 https://doi.org/10.1016/j.jaci.2017.04.014.
133. Hochwallner, H., Alm, J., Lupinek, C., Johansson, C., Mie, A., Scheynius, A., et al. Transmission of allergen-specific IgG and IgE from maternal blood into breast milk visualized with microarray technology. Journal of Allergy and Clinical Immunology 134:5 (2014), 1213–1215 https://doi.org/10.1016/j.jaci.2014.08.041.
134. Hochwallner, H., Schulmeister, U., Swoboda, I., Balic, N., Geller, B., Nystrand, M., et al. Microarray and allergenic activity assessment of milk allergens. Clinical and Experimental Allergy 40:12 (2010), 1809–1818 https://doi.org/10.1111/j.1365-2222.2010.03602.x.
135. Hochwallner, H., Schulmeister, U., Swoboda, I., Focke-Tejkl, M., Civaj, V., Balic, N., et al. Visualization of clustered IgE epitopes on alpha-lactalbumin. Journal of Allergy and Clinical Immunology 125:6 (2010), 1279–1285 https://doi.org/10.1016/j.jaci.2010.03.007.
136. Hofmaier, S., Hatzler, L., Rohrbach, A., Panetta, V., Hakimeh, D., Bauer, C.P., et al. “Default” versus “pre-atopic” IgG responses to foodborne and airborne pathogenesis-related group 10 protein molecules in birch-sensitized and nonatopic children. Journal of Allergy and Clinical Immunology 135:5 (2015), 1367–1374 https://doi.org/10.1016/j.jaci.2014.09.048.
137. Holloway, J.W., Yang, I.A., Holgate, S.T., Genetics of allergic disease. Journal of Allergy and Clinical Immunology 125:2 Suppl. 2 (2010), S81–94 https://doi.org/10.1016/j.jaci.2009.10.071.
138. Hong, X., Hao, K., Ladd-Acosta, C., Hansen, K.D., Tsai, H.J., Liu, X., et al. Genome-wide association study identifies peanut allergy-specific loci and evidence of epigenetic mediation in US children. Nature Communications, 24(6), 2015, 6304 https://doi.org/10.1038/ncomms7304.
139. Hradetzky, S., Roesner, L.M., Balaji, H., Heratizadeh, A., Mittermann, I., Valenta, R., et al. Cytokine effects induced by the human autoallergen α-NAC. The Journal of Investigative Dermatology 134:6 (2014), 1570–1578 https://doi.org/10.1038/jid.2014.25.
140. Huang, A.Y., Bruce, A.T., Pardoll, D.M., Levitsky, H.I., In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. Immunity 4:4 (1996), 349–355 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/8612129.
141. Huang, X., Tsilochristou, O., Perna, S., Hofmaier, S., Cappella, A., Bauer, C.P., et al. Evolution of the IgE and IgG repertoire to a comprehensive array of allergen molecules in the first decade of life. Allergy 73:2 (2018), 421–430 https://doi.org/10.1111/all.13269.
142. Incorvaia, C., Riario-Sforza, G.G., Ridolo, E., IgE depletion in severe asthma: What we have and what could be added in the near future. eBioMedicine 17 (2017), 16–17 https://doi.org/10.1016/j.ebiom.2017.02.023.
143. Ishizaka, K., Ishizaka, T., Identification of IgE. Journal of Allergy and Clinical Immunology 137:6 (2016), 1646–1650 https://doi.org/10.1016/j.jaci.2015.12.1343.
144. Ishizaka, K., Ishizaka, T., Hornbrook, M.M., Physicochemical properties of reaginic antibody. V. Correlation of reaginic activity wth gamma-E-globulin antibody. Journal of Immunology 97:6 (1966), 840–853 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/4163008.
145. Jacobsen, L., Niggemann, B., Dreborg, S., Ferdousi, H.A., Halken, S., Høst, A., et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 62:8 (2007), 943–948 https://doi.org/10.1111/j.1398-9995.2007.01451.x.
146. Jacquet, A., The role of the house dust mite-induced innate immunity in development of allergic response. International Archives of Allergy and Immunology 155:2 (2011), 95–105 https://doi.org/10.1159/000320375.
147. Jahn-Schmid, B., Fischer, G.F., Bohle, B., Fae, I., Gadermaier, G., Dedic, A., et al. Antigen presentation of the immunodominant T-cell epitope of the major mugwort pollen allergen, Art v 1, is associated with the expression of HLA-DRB1 *01. Journal of Allergy and Clinical Immunology 115:2 (2005), 399–404 https://doi.org/10.1016/j.jaci.2004.10.010.
148. James, L.K., Bowen, H., Calvert, R.A., Dodev, T.S., Shamji, M.H., Beavil, A.J., et al. Allergen specificity of IgG(4)-expressing B cells in patients with grass pollen allergy undergoing immunotherapy. Journal of Allergy and Clinical Immunology 130:3 (2012), 663–670 https://doi.org/10.1016/j.jaci.2012.04.006.
149. Johansson, S.G.O., The discovery of IgE. Journal of Allergy and Clinical Immunology 137:6 (2016), 1671–1673 https://doi.org/10.1016/j.jaci.2016.04.004.
150. Johansson, S.G., Bennich, H., Immunological studies of an atypical (myeloma) immunoglobulin. Immunology 13:4 (1967), 381–394 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/4168094.
151. Johansson, E.K., Bergström, A., Kull, I., Lind, T., Söderhäll, C., van Hage, M., et al. IgE sensitization in relation to preschool eczema and filaggrin mutation. Journal of Allergy and Clinical Immunology 140:6 (2017), 1572–1579 https://doi.org/10.1016/j.jaci.2017.04.008.
152. Katz, D.H., Paul, W.E., Goidl, E.A., Benacerraf, B., Carrier function in anti-hapten immune responses. I. Enhancement of primary and secondary anti-hapten antibody responses by carrier preimmunization. The Journal of Experimental Medicine 132:2 (1970), 261–282 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2138738/.
153. Kauffman, H.K., Tamm, M., Timmerman, J.A.B., Borger, P., House dust mite major allergens Der p 1 and Der p 5 activate human airway-derived epithelial cells by protease-dependent and protease-independent mechanisms. Clinical and Molecular Allergy, 4, 2006, 5 https://doi.org/10.1186/1476-7961-4-5.
154. Kawakami, T., Blank, U., From IgE to Omalizumab. Journal of Immunology 197:11 (2016), 4187–4192 https://doi.org/10.4049/jimmunol.1601476.
155. Kazemi-Shirazi, L., Niederberger, V., Linhart, B., Lidholm, J., Kraft, D., Valenta, R., Recombinant marker allergens: Diagnostic gatekeepers for the treatment of allergy. International Archives of Allergy and Immunology 127:4 (2002), 259–268.
156. Kelly, K.A. & Butch, A.W. (2007). Antigen-specific immunoglobulin E + B cells are preferentially localized within germinal centres. Immunology,120(3):345–53. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/17163956.
157. Kiel, M.A., Röder, E., Gerth van Wijk, R., Al, M.J., Hop, W.C., Rutten-van Mölken, M.P., Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. Journal of Allergy and Clinical Immunology 132:2 (2013), 353–360 e2 https://doi.org/10.1016/j.jaci.2013.03.013.
158. Kitzmüller, C., Nagl, B., Deifl, S., Walterskirchen, C., Jahn-Schmid, B., Zlabinger, G.J., et al. Human blood basophils do not act as antigen-presenting cells for the major birch pollen allergen Bet v 1. Allergy 67:5 (2012), 593–600 https://doi.org/10.1111/j.1398-9995.2011.02764.x.
159. Kulig, M., Bergmann, R., Klettke, U., Wahn, V., Tacke, U., Wahn, U., Natural course of sensitization to food and inhalant allergens during the first 6 years of life. Journal of Allergy and Clinical Immunology 103:6 (1999), 1173–1179 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/10359902.
160. Lambrecht, B.N., Peleman, R.A., Bullock, G.R., Pauwels, R.A., Sensitization to inhaled antigen by intratracheal instillation of dendritic cells. Clinical and Experimental Allergy 30:2 (2000), 214–224 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/10651774.
161. Larché, M., T cell epitope-based allergy vaccines. Current Topics in Microbiology and Immunology 352 (2011), 107–119 https://doi.org/10.1007/82_2011_131.
162. Larché, M., Akdis, C.A., Valenta, R., Immunological mechanisms of allergen-specific immunotherapy. Nature Reviews. Immunology 6:10 (2006), 761–771 https://doi.org/10.1038/nri1934.
163. Lawrence, M.G., Woodfolk, J.A., Schuyler, A.J., Stillman, L.C., Chapman, M.D., Platts-Mills, T.A., Half-life of IgE in serum and skin: Consequences for anti-IgE therapy in patients with allergic disease. Journal of Allergy and Clinical Immunology 139:2 (2017), 422–428 https://doi.org/10.1016/j.jaci.2016.04.056.
164. Leaker, B.R., Malkov, V.A., Mogg, R., Ruddy, M.K., Nicholson, G.C., Tan, A.J., et al. The nasal mucosal late allergic reaction to grass pollen involves type 2 inflammation (IL-5 and IL-13), the inflammasome (IL-1β), and complement. Mucosal Immunity 10:2 (2017), 408–420 https://doi.org/10.1038/mi.2016.74.
165. Leb, V.M., Jahn-Schmid, B., Schmetterer, K.G., Kueng, H.J., Haiderer, D., Neunkirchner, A., et al. Molecular and functional analysis of the antigen receptor of Art v 1-specific helper T lymphocytes. Journal of Allergy and Clinical Immunology 121:1 (2008), 64–71 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/18037161.
166. Leclerc, C., Sedlik, C., Lo-Man, R., Charlot, B., Rojas, M., Dériaud, E., Stimulation of a memory B cell response does not require primed helper T cells. European Journal of Immunology 25:9 (1995), 2533–2538 https://doi.org/10.1002/eji.1830250919.
167. Levin, M., Rotthus, S., Wendel, S., Najafi, N., Källström, E., Focke-Tejkl, M., et al. Multiple independent IgE epitopes on the highly allergenic grass pollen allergen Phl p 5. Clinical and Experimental Allergy 44:11 (2014), 1409–1419 https://doi.org/10.1111/cea.12423.
168. Lichtenstein, L.M., Osler, A.G., Studies on the mechanism of hypersensitivity phenomena. IX. Histamine release from human leukocytes by ragweed pollen antigen. The Journal of Experimental Medicine 120 (1964), 507–530 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2137776.
169. Linhart, B., Bigenzahn, S., Hartl, A., Lupinek, C., Thalhamer, J., Valenta, R., et al. Costimulation blockade inhibits allergic sensitization but does not affect established allergy in a murine model of grass pollen allergy. Journal of Immunology 178:6 (2007), 3924–3931 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993922.
170. Linhart, B., Valenta, R., Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives. Vaccine 30:29 (2012), 4328–4335 https://doi.org/10.1016/j.vaccine.2011.11.011.
171. Lotfi-Emran, S., Ward, B.R., Le, Q.T., Pozez, A.L., Manjili, M.H., Woodfolk, J.A., et al. Human mast cells present antigen to autologous CD4(+) T cells. Journal of Allergy and Clinical Immunology 141:1 (2018), 311–321 e10 https://doi.org/10.1016/j.jaci.2017.02.048.
172. Lucae, S., Schmid-Grendelmeier, P., Wüthrich, B., Kraft, D., Valenta, R., Linhart, B., IgE responses to exogenous and endogenous allergens in atopic dermatitis patients under long-term systemic cyclosporine A treatment. Allergy 71:1 (2016), 115–118 https://doi.org/10.1111/all.12711.
173. Lupinek, C., Derfler, K., Lee, S., Prikoszovich, T., Movadat, O., Wollmann, E., et al. Extracorporeal IgE immunoadsorption in allergic asthma: Safety and efficacy. eBioMedicine 17 (2017), 119–133 https://doi.org/10.1016/j.ebiom.2017.02.007.
174. Lupinek, C., Marth, K., Niederberger, V., Valenta, R., Analysis of serum IgE reactivity profiles with microarrayed allergens indicates absence of de novo IgE sensitizations in adults. Journal of Allergy and Clinical Immunology 130:6 (2012), 1418–1420 https://doi.org/10.1016/j.jaci.2012.06.028.
175. Lupinek, C., Roux, K.H., Laffer, S., Rauter, I., Reginald, K., Kneidinger, M., et al. Trimolecular complex formation of IgE, Fc epsilon RI, and a recombinant nonanaphylactic single-chain antibody fragment with high affinity for IgE. Journal of Immunology 182:8 (2009), 4817–4829 https://doi.org/10.4049/jimmunol.0800726.
176. Lupinek, C., Wollmann, E., Baar, A., Banerjee, S., Breiteneder, H., Broecker, B.M., et al. Advances in allergen-microarray technology for diagnosis and monitoring of allergy: The MeDALL allergen-chip. Methods 66:1 (2014), 106–119 https://doi.org/10.1016/j.ymeth.2013.10.008.
177. Lupinek, C., Wollmann, E., Valenta, R., Monitoring allergen immunotherapy effects by microarray. Current Treatment Options in Allergy 3 (2016), 189–203.
178. Lynch, N.R., Thomas, W.R., Chua, Y., García, N., Di Prisco, M.C., López, R., In vivo biological activity of recombinant Der p II allergen of house-dust mite. International Archives of Allergy and Immunology 105:1 (1994), 70–74 https://doi.org/10.1159/000236805.
179. Madritsch, C., Gadermaier, E., Roder, U.W., Lupinek, C., Valenta, R., Flicker, S., High-density IgE recognition of the major grass pollen allergen Phl p 1 revealed with single-chain IgE antibody fragments obtained by combinatorial cloning. Journal of Immunology 194:5 (2015), 2069–2078 https://doi.org/10.4049/jimmunol.1402185.
180. Manz, R.A., Arce, S., Cassese, G., Hauser, A.E., Hiepe, F., Radbruch, A., Humoral immunity and long-lived plasma cells. Current Opinion in Immunology 14:4 (2002), 517–521 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/12088688.
181. Manz, R.A., Thiel, A., Radbruch, A., Lifetime of plasma cells in the bone marrow. Nature 388:6638 (1997), 133–134 https://doi.org/10.1038/40540.
182. Marsh, D.G., Hsu, S.H., Roebber, M., Ehrlich-Kautzky, E., Freidhoff, L.R., Meyers, D.A., et al. HLA-Dw2: A genetic marker for human immune response to short ragweed pollen allergen Ra5. I. Response resulting primarily from natural antigenic exposure. The Journal of Experimental Medicine 155:5 (1982), 1439–1451 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2186667.
183. Marsh, D.G., Neely, J.D., Breazeale, D.R., Ghosh, B., Freidhoff, L.R., Ehrlich-Kautzky, E., et al. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 264:5162 (1994), 1152–1156 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/8178175.
184. Marth, K., Breyer, I., Focke-Tejkl, M., Blatt, K., Shamji, M.H., Layhadi, J., et al. A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype. Journal of Immunology 190:7 (2013), 3068–3078 https://doi.org/10.4049/jimmunol.1202441.
185. Marth, K., Novatchkova, M., Focke-Tejkl, M., Jenisch, S., Jäger, S., Kabelitz, D., et al. Tracing antigen signatures in the human IgE repertoire. Molecular Immunology 47:14 (2010), 2323–2329 https://doi.org/10.1016/j.molimm.2010.05.285.
186. Marth, K., Wollmann, E., Gallerano, D., Ndlovu, P., Makupe, I., Valenta, R., et al. Persistence of IgE-associated allergy and allergen-specific IgE despite CD4 + T cell loss in AIDS. PLoS One, 9(6), 2014, e97893 https://doi.org/10.1371/journal.pone.0097893.
187. Martino, D.J., Ashley, S., Koplin, J., Ellis, J., Saffery, R., Dharmage, S.C., et al. Genomewide association study of peanut allergy reproduces association with amino acid polymorphisms in HLA-DRB1. Clinical and Experimental Allergy 47:2 (2017), 217–223 https://doi.org/ https://doi.org/10.1111/cea.12863.
188. Matricardi, P.M., Kleine-Tebbe, J., Hoffmann, H.J., Valenta, R., Hilger, C., Hofmaier, S., et al. EAACI molecular allergology user's guide. Pediatric Allergy and Immunology 27:Suppl. 23 (2016), 1–250 https://doi.org/10.1111/pai.12563.
189. Maurer, D., Ebner, C., Reininger, B., Fiebiger, E., Kraft, D., Kinet, J.P., et al. The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation. Journal of Immunology 154:12 (1995), 6285–6290 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/7759866.
190. Menz, G., Dolecek, C., Schönheit-Kenn, U., Ferreira, F., Moser, M., Schneider, T., et al. Serological and skin-test diagnosis of birch pollen allergy with recombinant Bet v I, the major birch pollen allergen. Clinical and Experimental Allergy 26:1 (1996), 50–60 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/8789543.
191. Möller, C., Dreborg, S., Ferdousi, H.A., Halken, S., Høst, A., Jacobsen, L., et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). Journal of Allergy and Clinical Immunology 109:2 (2002), 251–256 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/11842293.
192. Moser, M., Crameri, R., Brust, E., Suter, M., Menz, G., Diagnostic value of recombinant Aspergillus fumigatus allergen I/a for skin testing and serology. Journal of Allergy and Clinical Immunology 93:1 Pt 1 (1994), 1–11 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/7508461.
193. Mothes, N., Heinzkill, M., Drachenberg, K.J., Sperr, W.R., Krauth, M.T., Majlesi, Y., et al. Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: Reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies. Clinical and Experimental Allergy 33:9 (2003), 1198–1208 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/12956739.
194. Movérare, R., Westritschnig, K., Svensson, M., Hayek, B., Bende, M., Pauli, G., et al. Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: An imprint of local sensitization. International Archives of Allergy and Immunology 128:4 (2002), 325–335 https://doi.org/10.1159/000063855.
195. Mudde, G.C., Bheekha, R., Bruijnzeel-Koomen, C.A., Consequences of IgE/CD23-mediated antigen presentation in allergy. Immunology Today 16:8 (1995), 380–383 https://doi.org/10.1016/0167-5699(95)80005-0.
196. Narayanan, M., Freidl, R., Focke-Tejkl, M., Baranyi, U., Wekerle, T., Valenta, R., et al. A B cell epitope peptide derived from the major grass pollen allergen Phl p 1 boosts allergen-specific secondary antibody responses without allergen-specific T cell help. Journal of Immunology 198:4 (2017), 1685–1695 https://doi.org/10.4049/jimmunol.1501741.
197. Neunkirchner, A., Kratzer, B., Köhler, C., Smole, U., Mager, L. F., Schmetterer, K. G., et al. (in press 2018). Genetic restriction of antigen-presentation dictates allergic sensitization and disease in humanized mice. eBioMedicine.
198. Niederberger, V., Eckl-Dorna, J., Pauli, G., Recombinant allergen-based provocation testing. Methods 66:1 (2014), 96–105 https://doi.org/10.1016/j.ymeth.2013.07.037.
199. Niederberger, V., Horak, F., Vrtala, S., Spitzauer, S., Krauth, M.T., Valent, P., et al. Vaccination with genetically engineered allergens prevents progression of allergic disease. Proceedings of the National Academy of Sciences of the United States of America 101:Suppl. 2 (2004), 14677–14682 https://doi.org/10.1073/pnas.0404735101.
200. Niederberger, V., Marth, K., Eckl-Dorna, J., Focke-Tejkl, M., Weber, M., Hemmer, W., et al. Skin test evaluation of a novel peptide carrier-based vaccine, BM32, in grass pollen-allergic patients. Journal of Allergy and Clinical Immunology 136:4 (2015), 1101–1103.e8 https://doi.org/10.1016/j.jaci.2015.03.034.
201. Niederberger, V., Neubauer, A., Gevaert, P., Zidarn, M., Worm, M., Aberer, W., et al. Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32. Journal of Allergy and Clinical Immunology, 2018 pii: S0091-6749(17)31884-5 https://doi.org/10.1016/j.jaci.2017.09.052.
202. Niederberger, V., Niggemann, B., Kraft, D., Spitzauer, S., & Valenta, R. (2002). Evolution of IgM, IgE and IgG(1–4) antibody responses in early childhood monitored with recombinant allergen components: Implications for class switch mechanisms. European Journal of Immunology, 32(2),576–584. https://doi.org/10.1002/1521-4141(200202)32:2<576::AID-IMMU576>3.0.CO;2-U.
203. Niederberger, V., Reisinger, J., Valent, P., Krauth, M.T., Pauli, G., van Hage, M., et al. Vaccination with genetically modified birch pollen allergens: Immune and clinical effects on oral allergy syndrome. Journal of Allergy and Clinical Immunology 119:4 (2007), 1013–1016 https://doi.org/10.1016/j.jaci.2006.12.661.
204. Niederberger, V., Ring, J., Rakoski, J., Jager, S., Spitzauer, S., Valent, P., et al. Antigens drive memory IgE responses in human allergy via the nasal mucosa. International Archives of Allergy and Immunology 142:2 (2007), 133–144 https://doi.org/10.1159/000096439.
205. Niemi, M., Jylhä, S., Laukkanen, M.L., Söderlund, H., Mäkinen-Kiljunen, S., Kallio, J.M., et al. Molecular interactions between a recombinant IgE antibody and the beta-lactoglobulin allergen. Structure 15:11 (2007), 1413–1421 https://doi.org/10.1016/j.str.2007.09.012.
206. Niespodziana, K., Focke-Tejkl, M., Linhart, B., Civaj, V., Blatt, K., Valent, P., et al. A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS. Journal of Allergy and Clinical Immunology 127:6 (2011), 1562–1570 https://doi.org/10.1016/j.jaci.2011.02.004.
207. Noon, L., Prophylactic inoculation against hay fever. Lancet 1 (1911), 1572–1573.
208. Nopp, A., Halldén, G., Lundahl, J., Johansson, E., Vrtala, S., Valenta, R., et al. Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen bet v 1 and to recombinant bet v 1 wild type in skin chamber fluids collected from birch pollen-allergic patients. Journal of Allergy and Clinical Immunology 106:1 Pt. 1 (2000), 101–109 https://doi.org/10.1067/mai.2000.106924.
209. Norman, P.S., Ohman, J.L., Jr., Long, A.A., Creticos, P.S., Gefter, M.A., Shaked, Z., et al. (1996). Treatment of cat allergy with T-cell reactive peptides. American Journal of Respiratory and Critical Care Medicine, 154(6), 1623–1628. https://doi.org/10.1164/ajrccm.154.6.8970345.
210. Ott, N.L., Gleich, G.J., Peterson, E.A., Fujisawa, T., Sur, S., Leiferman, K.M., Assessment of eosinophil and neutrophil participation in atopic dermatitis: Comparison with the IgE-mediated late-phase reaction. Journal of Allergy and Clinical Immunology 94:1 (1994), 120–128 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/8027490.
211. Padavattan, S., Flicker, S., Schirmer, T., Madritsch, C., Randow, S., Reese, G., et al. High-affinity IgE recognition of a conformational epitope of the major respiratory allergen Phl p 2 as revealed by X-ray crystallography. Journal of Immunology 182:4 (2009), 2141–2151 https://doi.org/10.4049/jimmunol.0803018.
212. Patel, D., Couroux, P., Hickey, P., Salapatek, A.M., Laidler, P., Larché, M., et al. Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: A randomized, placebo-controlled study. Journal of Allergy and Clinical Immunology 131:1 (2013), 103–109 e1–7 https://doi.org/10.1016/j.jaci.2012.07.028.
213. Pattarini, L., Trichot, C., Bogiatzi, S., Grandclaudon, M., Meller, S., Keuylian, Z., et al. TSLP-activated dendritic cells induce human T follicular helper cell differentiation through OX40-ligand. The Journal of Experimental Medicine 214:5 (2017), 1529–1546 https://doi.org/10.1084/jem.20150402.
214. Paul, S., Dillon, M.B.C., Arlehamn, C.S.L., Huang, H., Davis, M.M., McKinney, D.M., et al. A population response analysis approach to assign class II HLA-epitope restrictions. Journal of Immunology 194:12 (2015), 6164–6176 https://doi.org/10.4049/jimmunol.1403074.
215. Paul, W.E., Katz, D.H., Goidl, E.A., Benacerraf, B., Carrier function in anti-hapten immune responses. II. Specific properties of carrier cells capable of enhancing anti-hapten antibody responses. The Journal of Experimental Medicine 132:2 (1970), 283–299 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2138740/.
216. Pauli, G., Oster, J.P., Deviller, P., Heiss, S., Bessot, J.C., Susani, M., et al. Skin testing with recombinant allergens rBet v 1 and birch profilin, rBet v 2: Diagnostic value for birch pollen and associated allergies. Journal of Allergy and Clinical Immunology 97:5 (1996), 1100–1109 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/8626988.
217. Pearson, D.J., Freed, D.L., Taylor, G., Respiratory allergy and month of birth. Clinical and Experimental Allergy 7:1 (1977), 29–33.
218. Pennington, L.F., Tarchevskaya, S., Brigger, D., Sathiyamoorthy, K., Graham, M.T., Nadeau, K.C., et al. Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange. Nature Communications, 7, 2006, 11610 https://doi.org/10.1038/ncomms11610.
219. Perrier, C., Corthésy, B., Gut permeability and food allergies. Clinical and Experimental Allergy 41:1 (2011), 20–28 https://doi.org/10.1111/j.1365-2222.2010.03639.x.
220. Persson, H., Flicker, S., Sadegh, M.K., Greiff, L., Valenta, R., Ohlin, M., A common idiotype in IgE and its relation to recognition of the grass pollen allergen Phl p 2. Molecular Immunology 45:9 (2008), 2715–2720 https://doi.org/10.1016/j.molimm.2008.01.004.
221. Pham, J., Oseroff, C., Hinz, D., Sidney, J., Paul, S., Greenbaum, J., et al. Sequence conservation predicts T cell reactivity against ragweed allergens. Clinical and Experimental Allergy 46:9 (2016), 1194–1205 https://doi.org/10.1111/cea.12772.
222. Piliponsky, A.M., Gleich, G.J., Nagler, A., Bar, I., Levi-Schaffer, F., Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. Blood 101:5 (2003), 1898–1904 https://doi.org/10.1182/blood-2002-05-1488.
223. Piliponsky, A.M., Pickholtz, D., Gleich, G.J., Levi-Schaffer, F., Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: A possible role for mast cells in late-phase allergic reactions. Journal of Allergy and Clinical Immunology 107:6 (2001), 993–1000 https://doi.org/10.1067/mai.2001.114656.
224. Plantinga, M., Guilliams, M., Vanheerswynghels, M., Deswarte, K., Branco-Madeira, F., Toussaint, W., et al. Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity 38:2 (2013), 322–335 https://doi.org/10.1016/j.immuni.2012.10.016.
225. Portier, P., Richet, C., De l´action anaphylactique de certains venins. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 54 (1902), 170–172.
226. Posa, D., Perna, S., Resch, Y., Lupinek, C., Panetta, V., Hofmaier, S., et al. Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life. Journal of Allergy and Clinical Immunology 139:2 (2017), 541–549 https://doi.org/10.1016/j.jaci.2016.08.014.
227. Prausnitz, C., Küstner, H., Studien über die Überempfindlichkeit. Zentralblatt für Bakteriologie 86 (1921), 160–169.
228. Pree, I., Reisinger, J., Focke, M., Vrtala, S., Pauli, G., van Hage, M., et al. Analysis of epitope-specific immune responses induced by vaccination with structurally folded and unfolded recombinant Bet v 1 allergen derivatives in man. Journal of Immunology 179:8 (2007), 5309–5316 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/17911617.
229. Purohit, A., Niederberger, V., Kronqvist, M., Horak, F., Grönneberg, R., Suck, R., et al. Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives. Clinical and Experimental Allergy 38:9 (2008), 1514–1525 https://doi.org/10.1111/j.1365-2222.2008.03042.x.
230. Reich, K., Deinzer, J., Fiege, A.K., von Gruben, V., Sack, A.L., Thraen, A., et al. Panimmunoglobulin and IgE-selective extracorporeal immunoadsorption in patients with severe atopic dermatitis. Journal of Allergy and Clinical Immunology 137:6 (2016), 1882–1884 https://doi.org/10.1016/j.jaci.2016.01.016.
231. Reininger, R., Exner, H., Kuderna, C., Rumpold, H., Balic, N., Valenta, R., et al. Possible modes of allergen-specific sensitization and boosting in an atopic child. International Archives of Allergy and Immunology 130:4 (2003), 275–279 https://doi.org/10.1159/000070214.
232. Reinmuth-Selzle, K., Kampf, C.J., Lucas, K., Lang-Yona, N., Fröhlich-Nowoisky, J., Shiraiwa, M., et al. Air pollution and climate change effects on allergies in the anthropocene: Abundance, interaction, and modification of allergens and adjuvants. Environmental Science & Technology 51:8 (2017), 4119–4141 https://doi.org/10.1021/acs.est.6b04908.
233. Reisinger, J., Horak, F., Pauli, G., van Hage, M., Cromwell, O., König, F., et al. Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity. Journal of Allergy and Clinical Immunology 116:2 (2005), 347–354 https://doi.org/10.1016/j.jaci.2005.04.003.
234. Reisinger, J., Triendl, A., Küchler, E., Bohle, B., Krauth, M.T., Rauter, I., et al. IFN-gamma-enhanced allergen penetration across respiratory epithelium augments allergic inflammation. Journal of Allergy and Clinical Immunology 115:5 (2005), 973–981 https://doi.org/10.1016/j.jaci.2005.01.021.
235. Resch, Y., Michel, S., Kabesch, M., Lupinek, C., Valenta, R., Vrtala, S., Different IgE recognition of mite allergen components in asthmatic and nonasthmatic children. Journal of Allergy and Clinical Immunology 136:4 (2015), 1083–1091 https://doi.org/10.1016/j.jaci.2015.03.024.
236. Reynolds, L.A., Finlay, B.B., Early life factors that affect allergy development. Nature Reviews. Immunology 17:8 (2017), 518–528 https://doi.org/10.1038/nri.2017.39.
237. Rivera, A., Chen, C.C., Ron, N., Dougherty, J.P., Ron, Y., Role of B cells as antigen-presenting cells in vivo revisited: Antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations. International Immunology 13:12 (2001), 1583–1593 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/11717199.
238. Roesner, L.M., Heratizadeh, A., Wieschowski, S., Mittermann, I., Valenta, R., Eiz-Vesper, B., et al. α-NAC-specific autoreactive CD8 + T cells in atopic dermatitis are of an effector memory type and secrete IL-4 and IFN-γ. Journal of Immunology 196:8 (2016), 3245–3252 https://doi.org/10.4049/jimmunol.1500351.
239. Rusznak, C., Sapsford, R.J., Devalia, J.L., Justin John, R., Hewitt, E.L., Lamont, A.G., et al. Cigarette smoke potentiates house dust mite allergen-induced increase in the permeability of human bronchial epithelial cells in vitro. American Journal of Respiratory Cell and Molecular Biology 20:6 (1999), 1238–1250 https://doi.org/10.1165/ajrcmb.20.6.3226.
240. Saltabayeva, U., Garib, V., Morenko, M., Rosenson, R., Ispayeva, Z., Gatauova, M., et al. Greater real-life diagnostic efficacy of allergen molecule-based diagnosis for prescription of immunotherapy in an area with multiple pollen exposure. International Archives of Allergy and Immunology 173:2 (2017), 93–98.
241. Sastre, J., Landivar, M.E., Ruiz-García, M., Andregnette-Rosigno, M.V., Mahillo, I., How molecular diagnosis can change allergen-specific immunotherapy prescription in a complex pollen area. Allergy 67:5 (2012), 709–711 https://doi.org/10.1111/j.1398-9995.2012.02808.x.
242. Schuijs, M.J., Willart, M.A., Vergote, K., Gras, D., Deswarte, K., Ege, M.J., et al. Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells. Science 349:6252 (2015), 1106–1110 https://doi.org/10.1126/science.aac6623.
243. Schwarz, A., Panetta, V., Cappella, A., Hofmaier, S., Hatzler. L., Rohrbach, A., et al. (2016). IgG and IgG4 to 91 allergenic molecules in early childhood by route of exposure and current and future IgE sensitization: Results from the Multicentre Allergy Study birth cohort. Journal of Allergy and Clinical Immunology, 138(5), 1426–1433. https://doi.org/10.1016/j.jaci.2016.01.057.
244. Seiberler, S., Scheiner, O., Kraft, D., Lonsdale, D., Valenta, R., Characterization of a birch pollen allergen, Bet v III, representing a novel class of Ca2 + binding proteins: Specific expression in mature pollen and dependence of patients' IgE binding on protein-bound Ca2 +. The EMBO Journal 13:15 (1994), 3481–3486 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC395251.
245. Selb, R., Eckl-Dorna, J., Neunkirchner, A., Schmetterer, K., Marth, K., Gamper, J., et al. CD23 surface density on B cells is associated with IgE levels and determines IgE-facilitated allergen uptake, as well as activation of allergen-specific T cells. Journal of Allergy and Clinical Immunology 139:1 (2017), 290–299 https://doi.org/10.1016/j.jaci.2016.03.042.
246. Selb, R., Eckl-Dorna, J., Twaroch, T.E., Lupinek, C., Teufelberger, A., Hofer, G., et al. Critical and direct involvement of the CD23 stalk region in IgE binding. Journal of Allergy and Clinical Immunology 139:1 (2017), 281–289 https://doi.org/10.1016/j.jaci.2016.04.015.
247. Sellge, G., Laffer, S., Mierke, C., Vrtala, S., Hoffmann, M.W., Klempnauer, J., et al. Development of an in vitro system for the study of allergens and allergen-specific immunoglobulin E and immunoglobulin G: Fcepsilon receptor I supercross-linking is a possible new mechanism of immunoglobulin G-dependent enhancement of type I allergic reactions. Clinical and Experimental Allergy 35:6 (2005), 774–781 https://doi.org/10.1111/j.1365-2222.2005.02248.x.
248. Shamji, M.H., Kappen, J.H., Akdis, M., Jensen-Jarolim, E., Knol, E.F., Kleine-Tebbe, J., et al. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: An EAACI position paper. Allergy 72:8 (2017), 1156–1173 https://doi.org/10.1111/all.13138.
249. Shamji, M.H., Wilcock, L.K., Wachholz, P.A., Dearman, R.J., Kimber, I., Wurtzen, P.A., et al. The IgE-facilitated allergen binding (FAB) assay: Validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses. Journal of Immunological Methods 317:1-2 (2006), 71–79 https://doi.org/10.1016/j.jim.2006.09.004.
250. Shirakawa, T., Enomoto, T., Shimazu, S., Hopkin, J.M., The inverse association between tuberculin responses and atopic disorder. Science 275:5296 (1997), 77–79 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/8974396.
251. Shreffler, W.G., Castro, R.R., Kucuk, Z.Y., Charlop-Powers, Z., Grishina, G., Yoo, S., et al. The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro. Journal of Immunology 177:6 (2006), 3677–3685 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/16951327.
252. Simons, F.E., Imada, M., Li, Y., Watson, W.T., HayGlass, K.T., Fel d 1 peptides: Effect on skin tests and cytokine synthesis in cat-allergic human subjects. International Immunology 8:12 (1996), 1937–1945 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/8982778.
253. Siroux, V., Ballardini, N., Soler, M., Lupinek, C., Boudier, A., Pin, I., et al. The asthma-rhinitis multimorbidity is associated with IgE polysensitization in adolescents and adults. Allergy, 2018 https://doi.org/10.1111/all.13410.
254. Siroux, V., Lupinek, C., Resch, Y., Curin, M., Just, J., Keil, T., et al. Specific IgE and IgG measured by the MeDALL allergen-chip depend on allergen and route of exposure: The EGEA study. Journal of Allergy and Clinical Immunology 139:2 (2017), 643–654 https://doi.org/10.1016/j.jaci.2016.05.023.
255. Smole, U., Schabussova, I., Pickl, W.F., Wiedermann, U., Murine models for mucosal tolerance in allergy. Seminars in Immunology 30 (2017), 12–27 https://doi.org/10.1016/j.smim.2017.07.007.
256. Snow, R.E., Chapman, C.J., Frew, A.J., Holgate, S.T., Stevenson, F.K., Analysis of Ig VH region genes encoding IgE antibodies in splenic B lymphocytes of a patient with asthma. Journal of Immunology 154:10 (1995), 5576–5581 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/7730656.
257. Sokol, C.L., Chu, N.Q., Yu, S., Nish, S.A., Laufer, T.M., Medzhitov, R., Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nature Immunology 10:7 (2009), 713–720 https://doi.org/10.1038/ni.1738.
258. Solley, G.O., Gleich, G.J., Jordon, R.E., Schroeter, A.L., The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. The Journal of Clinical Investigation 58:2 (1976), 408–420 https://doi.org/10.1172/JCI108485.
259. Soto-Quiros, M., Avila, L., Platts-Mills, T.A., Hunt, J.F., Erdman, D.D., Carper, H., et al. High titers of IgE antibody to dust mite allergen and risk for wheezing among asthmatic children infected with rhinovirus. Journal of Allergy and Clinical Immunology 129:6 (2012), 1499–1505 https://doi.org/10.1016/j.jaci.2012.03.040.
260. Soyka, M.B., Wawrzyniak, P., Eiwegger, T., Holzmann, D., Treis, A., Wanke, K., et al. Defective epithelial barrier in chronic rhinosinusitis: The regulation of tight junctions by IFN-γ and IL-4. Journal of Allergy and Clinical Immunology 130:5 (2012), 1087–1096 https://doi.org/10.1016/j.jaci.2012.05.052.
261. Spertini, F., DellaCorte, G., Kettner, A., de Blay, F., Jacobsen, L., Jutel, M., et al. Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study. Journal of Allergy and Clinical Immunology 138:1 (2016), 162–168 https://doi.org/10.1016/j.jaci.2016.02.044.
262. Spertini, F., Perrin, Y., Audran, R., Pellaton, C., Boudousquié, C., Barbier, N., et al. Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides. Journal of Allergy and Clinical Immunology 134:1 (2014), 239–240 https://doi.org/10.1016/j.jaci.2014.04.001.
263. Steelant, B., Seys, S.F., Van Gerven, L., Van Woensel, M., Farré, R., Wawrzyniak, P., et al. Histamine and T helper cytokine-driven epithelial barrier dysfunction in allergic rhinitis. Journal of Allergy and Clinical Immunology, 141(3), 2018, 10.1016/j.jaci.2017.08.039 951.e8–963.e8.
264. Steinberger, P., Kraft, D., Valenta, R., Construction of a combinatorial IgE library from an allergic patient. Isolation and characterization of human IgE Fabs with specificity for the major timothy grass pollen allergen, Phl p 5. The Journal of Biological Chemistry 271:18 (1996), 10967–10972 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/8631916.
265. Stern, D.A., Riedler, J., Nowak, D., Braun-Fahrlander, C., Swoboda, I., Balic, N., et al. Exposure to a farming environment has allergen-specific protective effects on TH2-dependent isotype switching in response to common inhalants. Journal of Allergy and Clinical Immunology 119:2 (2007), 351–358 https://doi.org/10.1016/j.jaci.2006.10.013.
266. Stingl, G., Maurer, D., IgE-mediated allergen presentation via Fc epsilon RI on antigen-presenting cells. International Archives of Allergy and Immunology 113:1-3 (1997), 24–29 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/9130475.
267. Stringari, G., Tripodi, S., Caffarelli, C., Dondi, A., Asero, R., Di Rienzo Businco, A., et al. The effect of component-resolved diagnosis on specific immunotherapy prescription in children with hay fever. Journal of Allergy and Clinical Immunology 134:1 (2014), 75–81 https://doi.org/10.1016/j.jaci.2014.01.042.
268. Sutton, B.J., Davies, A.M., Structure and dynamics of IgE-receptor interactions: FcɛRI and CD23/FcɛRII. Immunological Reviews 268:1 (2015), 222–235 https://doi.org/10.1111/imr.12340.
269. Takhar, P., Smurthwaite, L., Coker, H.A., Fear, D.J., Banfield, G.K., Carr, V.A., et al. Allergen drives class switching to IgE in the nasal mucosa in allergic rhinitis. Journal of Immunology 174:8 (2005), 5024–5032 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/15814733.
270. Thomas, H.C., Parrott, M.V., The induction of tolerance to a soluble protein antigen by oral administration. Immunology 27:4 (1974), 631–639 Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1445717.
271. Traidl-Hoffmann, C., Mariani, V., Hochrein, H., Karg, K., Wagner, H., et al. Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization. The Journal of Experimental Medicine 201:4 (2005), 627–636 Erratum in: The Journal of Experimental Medicine, 201(8), 1347 https://doi.org/10.1084/jem.20041065.
272. Trompette, A., Divanovic, S., Visintin, A., Blanchard, C., Hegde, R.S., Madan, R., et al. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 457:7229 (2009), 585–588 https://doi.org/10.1038/nature07548.
273. Twaroch, T.E., Focke, M., Civaj, V., Weber, M., Balic, N., Mari, A., et al. Carrier-bound, nonallergenic Ole e 1 peptides for vaccination against olive pollen allergy. Journal of Allergy and Clinical Immunology 128:1 (2011), 178–184 https://doi.org/10.1016/j.jaci.2011.03.011.
274. Twaroch, T.E., Focke, M., Fleischmann, K., Balic, N., Lupinek, C., Blatt, K., et al. Carrier-bound Alt a 1 peptides without allergenic activity for vaccination against Alternaria alternata allergy. Clinical and Experimental Allergy 42:6 (2012), 966–975 https://doi.org/10.1111/j.1365-2222.2012.03996.x.
275. Uthoff, H., Spenner, A., Reckelkamm, W., Ahrens, B., Wölk, G., Hackler, R., et al. Critical role of preconceptional immunization for protective and nonpathological specific immunity in murine neonates. Journal of Immunology 171:7 (2003), 3485–3492 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/14500644.
276. Valent, P., Bettelheim, P., Cell surface structures on human basophils and mast cells: Biochemical and functional characterization. Advances in Immunology 52 (1992), 333–423 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/1332448.
277. Valenta, R., The future of antigen-specific immunotherapy of allergy. Nature Reviews. Immunology 2:6 (2002), 446–453 https://doi.org/10.1038/nri824.
278. Valenta, R., Biochemistry of allergens and recombinant allergens. Kay, A.B., Kaplan, A.P., Bousquet, J., Holt, P.G., (eds.) Allergy and allergic diseases, 2nd ed., 2008, Wiley-Blackwell, Chichester, 895–912.
279. Valenta, R., Oral tolerance induction in allergy: Kissing awake a sleeping beauty. Seminars in Immunolology 30 (2017), 1–2 https://doi.org/10.1016/j.smim.2017.08.016.
280. Valenta, R., Campana, R., Focke-Tejkl, M., Niederberger, V., Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future. Journal of Allergy and Clinical Immunology 137:2 (2016), 351–357 https://doi.org/10.1016/j.jaci.2015.12.1299.
281. Valenta, R., Campana, R., Marth, K., van Hage, M., Allergen-specific immunotherapy: From therapeutic vaccines to prophylactic approaches. Journal of Internal Medicine 272:2 (2012), 144–157 https://doi.org/10.1111/j.1365-2796.2012.02556.x.
282. Valenta, R., Campana, R., Niederberger, V., Recombinant allergy vaccines based on allergen-derived B cell epitopes. Immunology Letters 189 (2017), 19–26 https://doi.org/10.1016/j.imlet.2017.04.015.
283. Valenta, R., Duchene, M., Vrtala, S., Birkner, T., Ebner, C., Hirschwehr, R., et al. Recombinant allergens for immunoblot diagnosis of tree-pollen allergy. Journal of Allergy and Clinical Immunology 88:6 (1991), 889–894 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/1744359.
284. Valenta, R., Ferreira, F., Focke-Tejkl, M., Linhart, B., Niederberger, V., Swoboda, I., et al. From allergen genes to allergy vaccines. Annual Review of Immunology 28 (2010), 211–241 https://doi.org/10.1146/annurev-immunol-030409-101218.
285. Valenta, R., Hochwallner, H., Linhart, B., Pahr, S., Food allergies: The basics. Gastroenterology 148:6 (2015), 1120–1131 https://doi.org/10.1053/j.gastro.2015.02.006.
286. Valenta, R., Kraft, D., Recombinant allergen molecules: Tools to study effector cell activation. Immunological Reviews 179 (2001), 119–127 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/11292015.
287. Valenta, R., Lidholm, J., Niederberger, V., Hayek, B., Kraft, D., Grönlund, H., The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clinical and Experimental Allergy 29:7 (1999), 896–904 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/10383589.
288. Valenta, R., Linhart, B., Swoboda, I., Niederberger, V., Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens. Allergy 66:6 (2011), 775–783 https://doi.org/10.1111/j.1398-9995.2011.02565.x.
289. Valenta, R., Steinberger, P., Duchêne, M., Kraft, D., Immunological and structural similarities among allergens: Prerequisite for a specific and component-based therapy of allergy. Immunology and Cell Biology 74:2 (1996), 187–194 https://doi.org/10.1038/icb.1996.26.
290. Valenta, R., Twaroch, T., Swoboda, I., Component-resolved diagnosis to optimize allergen-specific immunotherapy in the Mediterranean area. Journal of Investigational Allergology and Clinical Immunology 17:Suppl. 1 (2007), 36–40 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/18050570.
291. Valenta, R., Vrtala, S., Ebner, C., Kraft, D., Scheiner, O., Diagnosis of grass pollen allergy with recombinant timothy grass (Phleum pratense) pollen allergens. International Archives of Allergy and Immunology 97:4 (1992), 287–294 https://doi.org/10.1159/000236135.
292. van der Heijden, F.L., van Neerven, R.J., van Katwijk, M., Bos, J.D., Kapsenberg, M.L., Serum-IgE-facilitated allergen presentation in atopic disease. Journal of Immunology 150:8 Pt. 1 (1993), 3643–3650 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/8468493.
293. van der Stoep, N., van der Linden, J., Logtenberg, T., Molecular evolution of the human immunoglobulin E response: High incidence of shared mutations and clonal relatedness among epsilon VH5 transcripts from three unrelated patients with atopic dermatitis. The Journal of Experimental Medicine 177:1 (1993), 99–107 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190866.
294. van Hage, M., Hamsten, C., Valenta, R., ImmunoCAP assays: Pros and cons in allergology. Journal of Allergy and Clinical Immunology 140:4 (2017), 974–977 https://doi.org/10.1016/j.jaci.2017.05.008.
295. van Neerven, R.J., Knol, E.F., Ejrnaes, A., Würtzen, P.A., IgE-mediated allergen presentation and blocking antibodies: Regulation of T-cell activation in allergy. International Archives of Allergy and Immunology 141:2 (2006), 119–129 https://doi.org/10.1159/000094714.
296. van Neerven, R.J., van de Pol, M.M., Wierenga, E.A., Aalberse, R.C., Jansen, H.M., Kapsenberg, M.L., Peptide specificity and HLA restriction do not dictate lymphokine production by allergen-specific T-lymphocyte clones. Immunology 82:3 (1994), 351–356 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1414890.
297. van Neerven, R.J., Wikborg, T., Lund, G., Jacobsen, B., Brinch-Nielsen, A., Arnved, J., et al. Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4 + T cells by inhibiting serum-IgE-facilitated allergen presentation. Journal of Immunology 163:5 (1999), 2944–2952 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/10453043.
298. van Ree, R., Carbohydrate epitopes and their relevance for the diagnosis and treatment of allergic diseases. International Archives of Allergy and Immunology 129:3 (2002), 189–197 https://doi.org/10.1159/000066770.
299. Vieira, P., Rajewsky, K., Persistence of memory B cells in mice deprived of T cell help. International Immunology 2:6 (1990), 487–494 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/2150759.
300. Visco, V., Dolecek, C., Denépoux, S., Le Mao, J., Guret, C., Rousset, F., et al. Human IgG monoclonal antibodies that modulate the binding of specific IgE to birch pollen Bet v 1. Journal of Immunology 157:2 (1996), 956–962 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/8752951.
301. von Mutius, E., Vercelli, D., Farm living: Effects on childhood asthma and allergy. Nature Reviews. Immunology 10:12 (2010), 861–868 https://doi.org/10.1038/nri2871.
302. von Pirquet, C., Allergie. Münchener Medizinische Wochenschrift 30 (1906), 1457–1461 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/347265.
303. Vrtala, S., Ball, T., Spitzauer, S., Pandjaitan, B., Suphioglu, C., Knox, B., et al. Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation. Journal of Immunology 160:12 (1998), 6137–6144 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/9637531.
304. Vrtala, S., Hirtenlehner, K., Susani, M., Akdis, M., Kussebi, F., Akdis, C.A., et al. Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1. The FASEB Journal 15:11 (2001), 2045–2047 https://doi.org/10.1096/fj.00-0767fje.
305. Vrtala, S., Hirtenlehner, K., Vangelista, L., Pastore, A., Eichler, H.G., Sperr, W.R., et al. Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: Candidates for a novel form of specific immunotherapy. The Journal of Clinical Investigation 99:7 (1997), 1673–1681 https://doi.org/10.1172/JCI119330.
306. Wan, H., Winton, H.L., Soeller, C., Tovey, E.R., Gruenert, D.C., Thompson, P.J., et al. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. The Journal of Clinical Investigation 104:1 (1999), 123–133 https://doi.org/10.1172/JCI5844.
307. Weber, M., Niespodziana, K., Linhart, B., Neubauer, A., Huber, H., Henning, R., et al. Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope-based grass pollen allergy vaccine with allergen extract-based vaccines. Journal of Allergy and Clinical Immunology 140:5 (2017), 1433–1436.e6 https://doi.org/10.1016/j.jaci.2017.03.048.
308. Weidinger, S., Novak, N., Atopic dermatitis. Lancet 387:10023 (2016), 1109–1122 https://doi.org/10.1016/S0140-6736(15)00149-X.
309. Wells, H.G., Osborne, T.B., The biological reactions of the vegetable proteins. The Journal of Infectious Diseases 8 (1911), 66–124 https://www.jstor.org/stable/30073318.
310. Werfel, T., Morita, A., Grewe, M., Renz, H., Wahn, U., Krutmann, J., et al. Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis. The Journal of Investigative Dermatology 107:6 (1996), 871–876 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/8941677.
311. Westman, M., Asarnoj, A., Hamsten, C., Wickman, M., van Hage, M., Windows of opportunity for tolerance induction for allergy by studying the evolution of allergic sensitization in birth cohorts. Seminars in Immunology 30 (2017), 61–66 https://doi.org/10.1016/j.smim.2017.07.005.
312. Westman, M., Lupinek, C., Bousquet, J., Andersson, N., Pahr, S., Baar, A., et al. Early childhood IgE reactivity to pathogenesis-related class 10 proteins predicts allergic rhinitis in adolescence. Journal of Allergy and Clinical Immunology 135:5 (2015), 1199–1206 https://doi.org/10.1016/j.jaci.2014.10.042.
313. Westritschnig, K., Horak, F., Swoboda, I., Balic, N., Spitzauer, S., Kundi, M., et al. Different allergenic activity of grass pollen allergens revealed by skin testing. European Journal of Clinical Investigation 38:4 (2008), 260–267 https://doi.org/10.1111/j.1365-2362.2008.01938.x.
314. Wickman, M., Lupinek, C., Andersson, N., Belgrave, D., Asarnoj, A., Benet, M., et al. Detection of IgE reactivity to a handful of allergen molecules in early childhood predicts respiratory allergy in adolescence. eBioMedicine 26 (2017), 91–99 https://doi.org/10.1016/j.ebiom.2017.11.009.
315. Wide, L., Bennich, H., Johansson, S.G., Diagnosis of allergy by an in-vitro test for allergen antibodies. Lancet 2:7526 (1967), 1105–1107 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/4168552.
316. Winther, L., Arnved, J., Malling, H.J., Nolte, H., Mosbech, H., Side-effects of allergen-specific immunotherapy: A prospective multi-centre study. Clinical and Experimental Allergy 36:3 (2006), 254–256 https://doi.org/10.1111/j.1365-2222.2006.02340.x.
317. Wollmann, E., Hamsten, C., Sibanda, E., Ochome, M., Focke-Tejkl, M., Asarnoj, A., et al. Natural clinical tolerance to peanut in African patients is caused by poor allergenic activity of peanut IgE. Allergy 70:6 (2015), 638–652 https://doi.org/10.1111/all.12592.
318. Wollmann, E., Lupinek, C., Kundi, M., Selb, R., Niederberger, V., Valenta, R., Reduction in allergen-specific IgE binding as measured by microarray: A possible surrogate marker for effects of specific immunotherapy. Journal of Allergy and Clinical Immunology 136:3 (2015), 806–809 https://doi.org/10.1016/j.jaci.2015.02.034.
319. Worm, M., Lee, H.H., Kleine-Tebbe, J., Hafner, R.P., Laidler, P., Healey, D., et al. Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy. Journal of Allergy and Clinical Immunology 127:1 (2011), 89–97 e1–14 https://doi.org/10.1016/j.jaci.2010.11.029.
320. Wu, L.C., Zarrin, A.A., The production and regulation of IgE by the immune system. Nature Reviews. Immunology 14:4 (2014), 247–259 https://doi.org/10.1038/nri3632.
321. H cell responses in a mouse model of asthma. Journal of Allergy and Clinical Immunology 141:4 (2018), 1395–1410, 10.1016/j.jaci.2017.09.001.
322. Xiong, H., Dolpady, J., Wabl, M., Curotto de Lafaille, M.A., Lafaille, J.J., Sequential class switching is required for the generation of high affinity IgE antibodies. The Journal of Experimental Medicine 209:2 (2012), 353–364 https://doi.org/10.1084/jem.20111941.
323. Zafred, D., Nandy, A., Pump, L., Kahlert, H., Keller, W., Crystal structure and immunologic characterization of the major grass pollen allergen Phl p 4. Journal of Allergy and Clinical Immunology 132:3 (2013), 696–703 https://doi.org/10.1016/j.jaci.2013.03.021.
324. Zieglmayer, P., Focke-Tejkl, M., Schmutz, R., Lemell, P., Zieglmayer, R., Weber, M., et al. Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy. eBioMedicine 11 (2016), 43–57 https://doi.org/10.1016/j.ebiom.2016.08.022.
325. Blackley, C.H., Experimental researches on the causes and nature of catarrhus aestivus (hay-fever or hay-asthma). Orginally published 1873, Tindall Cox, London 1959–2161, 1959, Dawson's of Pall Mall, London.
326. Bousquet, J., Gern, J.E., Martinez, F.D., Anto, J.M., Johnson, C.C., Holt, P.G., et al. Birth cohorts in asthma and allergic diseases: Report of a NIAID/NHLBI/MeDALL joint workshop. Journal of Allergy and Clinical Immunology 133:6 (2014), 1535–1546 https://doi.org/10.1016/j.jaci.2014.01.018.
327. Shaker, M., Salcone, E., An update on ocular allergy. Current Opinion in Allergy and Clinical Immunology 16:5 (2016), 505–510 https://doi.org/10.1097/ACI.0000000000000299.